KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemed (CHE) Asset Writedowns and Impairment (2016 - 2020)

Chemed filings provide 10 years of Asset Writedowns and Impairment readings, the most recent being -$443000.0 for Q4 2020.

  • For the quarter ending Q4 2020, Asset Writedowns and Impairment changed N/A year-over-year to -$443000.0, compared with a TTM value of $601000.0 through Dec 2020, changed N/A, and an annual FY2020 reading of $657000.0, changed N/A over the prior year.
  • Asset Writedowns and Impairment hit -$443000.0 in Q4 2020 for Chemed, down from $185000.0 in the prior quarter.
  • The five-year high for Asset Writedowns and Impairment was $4.7 million in Q3 2017, with the low at -$443000.0 in Q4 2020.
  • Median Asset Writedowns and Impairment over the past 3 years was $4.0 million (2016), compared with a mean of $2.9 million.
  • The largest YoY upside for Asset Writedowns and Impairment was 33.05% in 2016 against a maximum downside of 1.22% in 2016.
  • Year by year, Asset Writedowns and Impairment stood at $4.2 million in 2016, then increased by 3.96% to $4.4 million in 2017, then tumbled by 110.18% to -$443000.0 in 2020.
  • According to Business Quant data, Asset Writedowns and Impairment over the past three periods came in at -$443000.0, $185000.0, and $265000.0 for Q4 2020, Q3 2020, and Q2 2020 respectively.